Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.

British biotech CellCentric is settling into a new office in Boston, part of the company’s expansion into the U.S. as ...

This is Allison’s personal multiple myeloma story, and others may be different. Allison is a paid spokesperson for GSK.

Groundbreaking cancer treatment is taking place at Albany Medical Center.New York Oncology Hematology offering CAR-T therapy, ...

Chimeric antigen receptor t-cell, or CAR-T therapy, uses a person’s own immune cells to attack cancer. Dean Berhaupt is the ...

CINCINNATI (WKRC) — Dr. Will Smallwood, a cancer survivor and vice president of advancement at Cedarville University, is ...

Biomarker testing also extends beyond cancer care. The science is being used in the treatment of other diseases including ...

More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or ...

While we've known that a healthy diet reduces the overall chance of getting cancer, there's now evidence that one eating plan ...

A new research paper was published in , Volume 16, on March 21, 2025, titled "NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma." ...